Trademark: XCELLERATE CLINICAL TRIAL OPTIMIZATION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
XCELLERATE CLINICAL TRIAL OPTIMIZATION
Click here to search for trademarks similar to XCELLERATE CLINICAL TRIAL OPTIMIZATION
Proof of use for XCELLERATE CLINICAL TRIAL OPTIMIZATION
We do not have any records of a proof of use for XCELLERATE CLINICAL TRIAL OPTIMIZATION at this moment.
Click here to add a proof of use for XCELLERATE CLINICAL TRIAL OPTIMIZATION
Possible trademark infringements of XCELLERATE CLINICAL TRIAL OPTIMIZATION
Basic Information about XCELLERATE CLINICAL TRIAL OPTIMIZATION
- Serial Number
- 85421531
- Filing Date
- 13 Sep 2011
- Registration Number
- 4145934
- Registration Date
- 22 May 2012
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of XCELLERATE CLINICAL TRIAL OPTIMIZATION on the blockchain with WikiTrademarks.io.
- First use of XCELLERATE CLINICAL TRIAL OPTIMIZATION anywhere
- XCELLERATE CLINICAL TRIAL OPTIMIZATION was first used on 01 Mar 2011 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 042
- US Codes
- 100; 101
Who owns XCELLERATE CLINICAL TRIAL OPTIMIZATION?
1. LABCORP DRUG DEVELOPMENT INC. PRINCETON NJ
2. Covance Inc. Princeton NJ
3. Covance Inc. Princeton NJ
4. Covance Inc. Princeton NJ
Correspondent
- William M. Bryner
- Kilpatrick Townsend & Stockton LLP
- 1001 West Fourth Street
- Winston-Salem, NC 27101
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io